SCHEMBL4897635

SCHEMBL4897635

CCN(c1ccc(-c2ccc(C(F)(F)F)cc2)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 2/20 0.53
LMNA P02545 1/20 0.49
HDAC3 O15379 1/20 0.48
HDAC11 Q96DB2 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
RORC P51449 3/20 0.47
NR1I2 O75469 1/20 0.47
RORA P35398 1/20 0.47
NR1H2 P55055 1/20 0.47
NR1H3 Q13133 1/20 0.47
RORB Q92753 1/20 0.47
NR1H4 Q96RI1 1/20 0.47
HSD11B1 P28845 1/20 0.47
MAPK1 P28482 1/20 0.46
POLB P06746 2/20 0.44
ESR1 P03372 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
MAPT P10636 1/20 0.44
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906301 0.91 HDAC8 (0.51) HDAC8LMNAHDAC3HDAC11HDAC6
SCHEMBL4895643 0.89 HDAC8 (0.53) HDAC8LMNAHDAC3HDAC11HDAC6
SCHEMBL4903714 0.88 LMNA (0.56) HDAC8LMNAHDAC3HDAC11HDAC6
SCHEMBL4897462 0.87 HCRTR2 (0.51) HDAC8LMNARORCNR1I2RORA
SCHEMBL4897727 0.86 MMP2 (0.48) HDAC8LMNAHDAC3HDAC11HDAC6
SCHEMBL4911906 0.83 HDAC8 (0.39) HDAC8LMNAHDAC3HDAC11HDAC6
SCHEMBL4901379 0.82 KDM4E (0.41) HDAC8LMNANR1H4MAPTALDH1A1
SCHEMBL4906417 0.81 HDAC8 (0.52) HDAC8HDAC3HDAC11HDAC6RORC
SCHEMBL4904446 0.81 HCRTR2 (0.51) HDAC8LMNAMAPK1ESR1ALDH1A1
SCHEMBL4904134 0.80 LMNA (0.54) HDAC8LMNAHDAC3HDAC11HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD HDAC8 882/4885LMNA 319/4885HDAC3 157/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD HDAC8 882/4885LMNA 319/4885HDAC3 157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.